At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Observational Descriptive Study and Retrospective Chart Review of Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
In Brief
An observational study evaluating Retrospective Chart Review, Patient-reported Outcome Questionnaires, and 1 other intervention for Idiopathic Thrombocytopenic Purpura and 3 related conditions. Completed, enrolled 326 participants.
Detailed Summary
This is a multi-center prospective observational descriptive study complemented by a retrospective chart review. Patients diagnosed with ITP and currently treated for ITP by a hematologist or hematologist-oncologist will be recruited from community-based clinics and academic/referral centers. They will be followed prospectively for a period of 12 months. At inception, participants' charts will also be reviewed from the date of enrollment retrospectively to the date of diagnosis or the previous 36 months, whichever is less.
Study Details
Timeline
Interventions
Retrospective chart review for up to 36 months of enrollment date.
Quality of lige questionnaires as well as treatment satisfaction questionnaires are required monthly. Includes QOL, ITP-PAQ (immune thrombocytopenic purpura - patient assessment questionnaire), EQ-5D, and TSQM (Treatment Satisfaction Questionnaire for Medication).
Physician characteristics to be collected include demographics, years of practice, medical specialty or primary treating physician, and the referral process.